About: http://webisa.webdatacommons.org/363260915

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Part A is a randomized, double-blind, placebo-controlled, parallel-group, dose-ranging design and Part B is an optional, open label extension design.
http://www.w3.org/ns/prov#wasQuotedFrom	clinicaltrials.gov